Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Co-Diagnostics, Inc.

NASDAQ: CODX · Industrial Applications and Services · 11 alerts · CIK 1692415

Share price
$0.2249Close, Nov 16
Market cap
$2.36M
Shares outstanding
10.51MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Co-Diagnostics, Inc. filings on SEC EDGAR ↗

5:01 PM ET 8-K
Shareholder Meeting

Co-Diagnostics Shareholder Meeting

Co-Diagnostics held a court-ordered special meeting of shareholders on November 13, 2026, where shareholders elected five directors and approved an amendment to the 2025 Equity Incentive Plan. The amendment increases the number of shares authorized for issuance under the plan by 2,000,000 shares, bringing the total maximum to 2,223,333 shares. Shareholders also approved a non-binding advisory resolution regarding executive compensation.

4:16 PM ET 8-K
Shareholder Meeting

Co-Diagnostics Shareholder Meeting

Co-Diagnostics, Inc. reconvened its 2026 Annual Meeting of Stockholders on October 14, 2026, but was unable to transact business because a quorum was not present. The company determined not to adjourn the meeting again and intends to seek stockholder approval for the proposals at a future special meeting.

6:02 AM ET 8-K
Shareholder Meeting

Co-Diagnostics Shareholder Meeting

Co-Diagnostics, Inc. announced that its 2026 Annual Meeting of Stockholders has been adjourned for a third time to October 14, 2026, due to a failure to achieve a quorum. The company was unable to transact any business at the original September 3 meeting or the subsequent adjournments on September 24 and September 30. Stockholders of record as of the original July 14, 2026 record date remain eligible to vote at the reconvened meeting.

4:46 PM ET 8-K
Shareholder Meeting

Co-Diagnostics Shareholder Meeting

Co-Diagnostics, Inc. has postponed its Annual Meeting of Stockholders for a second time after failing to achieve a quorum on September 24, 2026. The meeting has been rescheduled for September 30, 2026, at the company's offices in Salt Lake City, Utah.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.